Residual risk is the risk that remains after all the planned risk treatments have been implemented. Residual risk is the risk that remains after all the planned risk treatments have been implemented.

In 2014, the Robotics Industry Association (RIA) published RIA TR R15.306 (Technical Report for Industrial Robots and Robot Systems—Safety Requirements—Task-based Risk Assessment Methodology). The ...

The residual cancer burden index was developed as a method to quantify residual disease ranging from pathological complete response to extensive residual disease. The aim of this study was to evaluate ...

Tumor infiltrating lymphocytes to predict DFS from intense dose-dense (idd) EPC regimen: Results from the German Adjuvant Intergroup Node-positive study (GAIN-1). This is an ASCO Meeting Abstract from ...

The management of atherosclerotic cardiovascular disease (ASCVD) requires highly personalized lipid strategies, particularly ...

Flow MRD, also offering a high sensitivity (up to 10 −4), is applicable in >90% of all cases. 7, 9, 12 The basis of flow MRD is the definition and detection of leukemia-associated aberrant ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — The medical community is better equipped to combat residual CVD risk than previously, but prevention of ...

Industry has been implementing the requirements of NFPA 70E, Standard for Electrical Safety in the Workplace, for more than 20 years. The recently published 2024 Edition continues in its refinement of ...

The extent of residual prostate cancer in the surgical specimen following intensified neoadjuvant therapy for high-risk localized prostate cancer may predict metastatic recurrence. Residual disease ...